Anavex Life Sciences CORP DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Anavex Life Sciences Corp. has filed a definitive proxy statement with the SEC.
NASDAQ
Anavex Life Sciences is asking stockholders to approve an amendment to its 2022 Omnibus Incentive Plan, including increasing the number of shares available and establishing a minimum vesting period.
NASDAQ
ANAVEX Life Sciences Corp. has filed a definitive proxy statement with the SEC.
NASDAQ
Anavex Life Sciences Corp. has released its proxy statement outlining the agenda and procedures for its 2024 Annual Meeting of Stockholders, scheduled for June 18, 2024.